JamesMichaelParksMD
Cardiology • Birmingham, ALAdult Congenital Heart Disease, Interventional Cardiology
Physician
Dr. Parks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
833 Saint Vincents Dr
Ste 300
Birmingham, AL 35205Phone+1 205-939-4512Fax+1 205-939-4519
Summary
- Dr. James Parks is a cardiologist in Birmingham, AL and is affiliated with St. Vincent's Birmingham. He received his medical degree from University of Alabama School of Medicine and has been in practice 32 years. He specializes in adult congenital heart disease, and interventional cardiology and is experienced in carotid artery stenting, peripheral endovascular interventional cardiology, structural heart, and coronary stenting.
Education & Training
University of Alabama Medical CenterPost-Doctoral Fellowship, Interventional Cardiology, 1992 - 1993- University of Alabama Medical CenterFellowship, Cardiovascular Disease, 1989 - 1992
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1985 - 1988
University of Alabama School of MedicineClass of 1985
Certifications & Licensure
AL State Medical License 1989 - 2024
TX State Medical License 1987 - 1994- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FACC) American College of Cardiology, 1995
- Alpha Omega Alpha 1985
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsPlatelet activation and restenosis after coronary stenting: flow cytometric detection of wound-induced platelet activation.Jerome H. Markovitz, Gary S. Roubin, J. Parks, Vera Bittner
Coronary Artery Disease. 1996-09-01 - 19 citationsHypertriglyceridemic VLDL Decreases Plasminogen Binding to Endothelial Cells and Surface-Localized Fibrinolysis†Xin-Nong Li, J. C. Koons, Raymond L. Benza, J. M. Parks, V. K. Varma
Biochemistry. 1996-05-14 - 22 citationsThrombin Decreases the Urokinase Receptor and Surface-Localized Fibrinolysis in Cultured Endothelial CellsXin-Nong Li, V. K. Varma, J. M. Parks, Raymond L. Benza, J. C. Koons
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995-03-01
Professional Memberships
- Fellow
- Southeastern Clinical ClubMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
